October 21-25, 2020
Please join our oral presentation on, “Broad and Prevalent SARS-CoV-2 CD8+ T Cell Response in Recovered COVID-19 Individuals Demonstrates Kinetics of Early Differentiation” and meet our team!
Session Date: Saturday October 24, 2020
Session Time: 1:15 PM – 3:00 PM
Come visit ImmunoScape’s virtual booth at the IDWeek 2020™ and chat with us!
In this study, using our multiplexed peptide-MHC tetramer approach to screen 408 SARS-CoV-2 candidate epitopes for CD8+ T cell recognition, we identified 52 unique epitope hits (18 unreported), spanning different viral proteins. Insights gained from these SARS-CoV-2 reactivities and their associated T cell profiles capable of differentiating into long-term mediators of protection may guide the rational design of COVID-19 vaccine candidates to curb this pandemic.